Hi All RAP Holders, Have not been able to post due to ongoing global travel commitments and lack of time but have read some interesting and unfortunately at times some misguided posts no doubt stemming from various personal situations and agendas.
Lets stick to some facts.
1) CR - The company was, is and has always been funded for FDA approval in Paediatric Pneumonia. Nothing changes. With over $2mil in hand and a hefty R&D incentive due soon added to the well managed low outgoing costs the CR has absolutely nothing to do with the FDA Paediatric Pneumonia Approval. I believe that is fairly obvious to see. Now I will say there is a cost to request a EAP which I have been mentioning for awhile, though a CR for the individual FDA EAP was not required.
"
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/ucm441467.htm"
Read some of the text regarding this process, its purpose and outcomes and connect the dots.
2) The volume of tests and results have allowed us to progress other diagnosis and meet other market demands earlier then initially expected. The workload to progress and utilise this data to meet the medical demand is HUGE, the workload on the ResApp team is HUGE, It would be foolish of our management to not act on this now. I am bewildered that some people seem to not bother to read the news flow or take the time to talk to management and are unable to see that ResApp is progressing at a more rapid pace then anyone was able to predict. Is that not a good thing??
On a finishing note;
I have no idea or guarantees in future stock prices, or if the hole in the ground holding commodity X will ever even make it out of that hole, or if some "Internet of things" invention X is better then Y etc (though I do enjoy trading on these specs).
I do however know every day I wake up the population has grown, air pollution has increased, the spread of viral bacteria has increased and the need for Fast, Easy and Accessible diagnosis of medical conditions is required.
Just remember that our technology is able to diagnosis multiple diseases, in varied circumstances and all around the globe. I say do what you want with your shares and comment how you please but show some respect to a management team that has thus far done a fantastic job steering this company in the right direction.
2c's finished
